LOTEMAX SM Is Formulated with SubMicron Technology for Efficient Penetration To Key Ocular Tissues 1 BRIDGEWATER, N.J., Feb. 25, 2019 /CNW/ -- Bausch + Lomb, a leading global eye health company and ...

The FINANCIAL — MADISON, NJ—Bausch + Lomb, the global eye health company, has added a new product to its signature loteprednol etabonate line: LOTEMAX® Ointment. LOTEMAX Ointment is indicated to treat ...

Lupin has received approval from the Food and Drug Administration for loteprednol etabonate ophthalmic gel, 0.38%, which is the generic of Bausch & Lomb’s Lotemax SM Ophthalmic Gel. Lupin is the ...

Bausch + Lomb has announced it has received FDA approval of the company’s new drug application for LOTEMAX 0.5 percent gel drop formulation, according to a news release. The LOTEMAX (loteprednol ...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...